Annovis Bio, Inc. (ANVS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the 2025 Annual Meeting of Stockholders held virtually on June 17, 2025. Annovis Bio, Inc., a Delaware corporation and emerging growth company, reported the final voting results for two proposals submitted to its security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance.
Material Changes and Voting Results
A total of 11,588,981 shares, representing 59.47% of the common stock outstanding as of the April 28, 2025 record date, were represented at the meeting. Both proposals were approved:
- Election of Directors: All five nominees were elected to serve one-year terms. Voting breakdown included significant broker non-votes (7,199,431) for each nominee.
- Maria Maccecchini: 4,216,112 For; 173,438 Withheld
- Michael Hoffman: 4,182,806 For; 206,744 Withheld
- Claudine Bruck: 4,041,007 For; 348,543 Withheld
- Reid McCarthy: 4,202,391 For; 187,159 Withheld
- Mark White: 3,780,238 For; 609,312 Withheld
- Ratification of Independent Auditors: The appointment of Ernst & Young LLP was approved.
- For: 11,382,542
- Against: 187,959
- Abstain: 18,480
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the results of the stockholder vote.
Investor Verification Checklist
- Verify the definitive proxy statement for detailed biographies of the newly elected directors and the rationale for the auditor ratification.
- Confirm the total number of shares outstanding as of the record date to validate the 59.47% participation rate.
- Review the company's most recent 10-K or 10-Q filings for financial metrics, as this 8-K contains no financial data.
- Monitor the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.